ANI Pharmaceuticals | ANIP - Gross Profit On Sales


ANI Pharmaceuticals reported $124.18M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Aurora Cannabis CAD 29.79M 16.83M Mar/2026
Canopy Growth CAD 8.26M 13.2M Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
Heron Therapeutics USD 29.47M 3.17M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Novartis USD 10.07B 758M Mar/2026
Omeros USD -33.16M 18.52M Jun/2024
Perrigo USD 325.5M 36.7M Mar/2026
Sun Pharmaceuticals INR 125.24B 17.58B Dec/2025
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026